Report Detail

Request for Sample of this report

Pharma & Healthcare Global Cancer Pain Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4598908
    • |
  • 02 July, 2024
    • |
  • Global
    • |
  • 111 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Cancer Pain market size was valued at USD 6377.4 million in 2023 and is forecast to a readjusted size of USD 8959.6 million by 2030 with a CAGR of 5.0% during review period.
Cancer pain is one of the most common symptoms in cancer patients. Pain can be caused by cancer, cancer treatment, or a combination of factors.
The growth of the global cancer pain market is mainly due to the increasing prevalence of cancer; rising geriatric population; rising healthcare expenditure; and increasing investment in research and development activities by various healthcare companies. Due to aging effects and genetic mutations, older people are more prone to various types of cancer, such as lung cancer, bladder cancer, kidney cancer, melanoma, etc. According to the National Cancer Institute, the median age at diagnosis is 61 for breast cancer, 68 for colorectal cancer, 70 for lung cancer and 66 for prostate cancer. However, side effects associated with drugs used in cancer pain treatment, such as drug tolerance, drug dependence, urinary retention, sleep disturbance, cognitive impairment, etc., are expected to restrain the growth of the cancer pain market over the forecast period.
The Global Info Research report includes an overview of the development of the Cancer Pain industry chain, the market status of Radiotherapy (Opioids, Non-Steroidal Anti-Inflammatory Drugs), Chemotherapy (Opioids, Non-Steroidal Anti-Inflammatory Drugs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cancer Pain.
Regionally, the report analyzes the Cancer Pain markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cancer Pain market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cancer Pain market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cancer Pain industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Opioids, Non-Steroidal Anti-Inflammatory Drugs).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cancer Pain market.
Regional Analysis: The report involves examining the Cancer Pain market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cancer Pain market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cancer Pain:
Company Analysis: Report covers individual Cancer Pain players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cancer Pain This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Radiotherapy, Chemotherapy).
Technology Analysis: Report covers specific technologies relevant to Cancer Pain. It assesses the current state, advancements, and potential future developments in Cancer Pain areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cancer Pain market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cancer Pain market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Opioids
Non-Steroidal Anti-Inflammatory Drugs
Others
Market segment by Application
Radiotherapy
Chemotherapy
Hormone Therapy
Others
Market segment by players, this report covers
BioDelivery Science
ProStrakan Group
Teva pharmaceuticals
Eli-Lilly
Grunenthal Group
GW Pharmaceuticals
Johnson＆Johnson
Meda Pharmaceuticals
Orexo
Sanofi
WEX Pharmaceuticals
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cancer Pain product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cancer Pain, with revenue, gross margin and global market share of Cancer Pain from 2019 to 2024.
Chapter 3, the Cancer Pain competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cancer Pain market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Pain.
Chapter 13, to describe Cancer Pain research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Cancer Pain
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cancer Pain by Type
    • 1.3.1 Overview: Global Cancer Pain Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Cancer Pain Consumption Value Market Share by Type in 2023
    • 1.3.3 Opioids
    • 1.3.4 Non-Steroidal Anti-Inflammatory Drugs
    • 1.3.5 Others
  • 1.4 Global Cancer Pain Market by Application
    • 1.4.1 Overview: Global Cancer Pain Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Radiotherapy
    • 1.4.3 Chemotherapy
    • 1.4.4 Hormone Therapy
    • 1.4.5 Others
  • 1.5 Global Cancer Pain Market Size & Forecast
  • 1.6 Global Cancer Pain Market Size and Forecast by Region
    • 1.6.1 Global Cancer Pain Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Cancer Pain Market Size by Region, (2019-2030)
    • 1.6.3 North America Cancer Pain Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Cancer Pain Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Cancer Pain Market Size and Prospect (2019-2030)
    • 1.6.6 South America Cancer Pain Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Cancer Pain Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 BioDelivery Science
    • 2.1.1 BioDelivery Science Details
    • 2.1.2 BioDelivery Science Major Business
    • 2.1.3 BioDelivery Science Cancer Pain Product and Solutions
    • 2.1.4 BioDelivery Science Cancer Pain Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 BioDelivery Science Recent Developments and Future Plans
  • 2.2 ProStrakan Group
    • 2.2.1 ProStrakan Group Details
    • 2.2.2 ProStrakan Group Major Business
    • 2.2.3 ProStrakan Group Cancer Pain Product and Solutions
    • 2.2.4 ProStrakan Group Cancer Pain Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 ProStrakan Group Recent Developments and Future Plans
  • 2.3 Teva pharmaceuticals
    • 2.3.1 Teva pharmaceuticals Details
    • 2.3.2 Teva pharmaceuticals Major Business
    • 2.3.3 Teva pharmaceuticals Cancer Pain Product and Solutions
    • 2.3.4 Teva pharmaceuticals Cancer Pain Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Teva pharmaceuticals Recent Developments and Future Plans
  • 2.4 Eli-Lilly
    • 2.4.1 Eli-Lilly Details
    • 2.4.2 Eli-Lilly Major Business
    • 2.4.3 Eli-Lilly Cancer Pain Product and Solutions
    • 2.4.4 Eli-Lilly Cancer Pain Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Eli-Lilly Recent Developments and Future Plans
  • 2.5 Grunenthal Group
    • 2.5.1 Grunenthal Group Details
    • 2.5.2 Grunenthal Group Major Business
    • 2.5.3 Grunenthal Group Cancer Pain Product and Solutions
    • 2.5.4 Grunenthal Group Cancer Pain Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Grunenthal Group Recent Developments and Future Plans
  • 2.6 GW Pharmaceuticals
    • 2.6.1 GW Pharmaceuticals Details
    • 2.6.2 GW Pharmaceuticals Major Business
    • 2.6.3 GW Pharmaceuticals Cancer Pain Product and Solutions
    • 2.6.4 GW Pharmaceuticals Cancer Pain Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 GW Pharmaceuticals Recent Developments and Future Plans
  • 2.7 Johnson＆Johnson
    • 2.7.1 Johnson＆Johnson Details
    • 2.7.2 Johnson＆Johnson Major Business
    • 2.7.3 Johnson＆Johnson Cancer Pain Product and Solutions
    • 2.7.4 Johnson＆Johnson Cancer Pain Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Johnson＆Johnson Recent Developments and Future Plans
  • 2.8 Meda Pharmaceuticals
    • 2.8.1 Meda Pharmaceuticals Details
    • 2.8.2 Meda Pharmaceuticals Major Business
    • 2.8.3 Meda Pharmaceuticals Cancer Pain Product and Solutions
    • 2.8.4 Meda Pharmaceuticals Cancer Pain Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Meda Pharmaceuticals Recent Developments and Future Plans
  • 2.9 Orexo
    • 2.9.1 Orexo Details
    • 2.9.2 Orexo Major Business
    • 2.9.3 Orexo Cancer Pain Product and Solutions
    • 2.9.4 Orexo Cancer Pain Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Orexo Recent Developments and Future Plans
  • 2.10 Sanofi
    • 2.10.1 Sanofi Details
    • 2.10.2 Sanofi Major Business
    • 2.10.3 Sanofi Cancer Pain Product and Solutions
    • 2.10.4 Sanofi Cancer Pain Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Sanofi Recent Developments and Future Plans
  • 2.11 WEX Pharmaceuticals
    • 2.11.1 WEX Pharmaceuticals Details
    • 2.11.2 WEX Pharmaceuticals Major Business
    • 2.11.3 WEX Pharmaceuticals Cancer Pain Product and Solutions
    • 2.11.4 WEX Pharmaceuticals Cancer Pain Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 WEX Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cancer Pain Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Cancer Pain by Company Revenue
    • 3.2.2 Top 3 Cancer Pain Players Market Share in 2023
    • 3.2.3 Top 6 Cancer Pain Players Market Share in 2023
  • 3.3 Cancer Pain Market: Overall Company Footprint Analysis
    • 3.3.1 Cancer Pain Market: Region Footprint
    • 3.3.2 Cancer Pain Market: Company Product Type Footprint
    • 3.3.3 Cancer Pain Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cancer Pain Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Cancer Pain Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Cancer Pain Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Cancer Pain Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Cancer Pain Consumption Value by Type (2019-2030)
  • 6.2 North America Cancer Pain Consumption Value by Application (2019-2030)
  • 6.3 North America Cancer Pain Market Size by Country
    • 6.3.1 North America Cancer Pain Consumption Value by Country (2019-2030)
    • 6.3.2 United States Cancer Pain Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Cancer Pain Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Cancer Pain Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Cancer Pain Consumption Value by Type (2019-2030)
  • 7.2 Europe Cancer Pain Consumption Value by Application (2019-2030)
  • 7.3 Europe Cancer Pain Market Size by Country
    • 7.3.1 Europe Cancer Pain Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Cancer Pain Market Size and Forecast (2019-2030)
    • 7.3.3 France Cancer Pain Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Cancer Pain Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Cancer Pain Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Cancer Pain Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cancer Pain Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Cancer Pain Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Cancer Pain Market Size by Region
    • 8.3.1 Asia-Pacific Cancer Pain Consumption Value by Region (2019-2030)
    • 8.3.2 China Cancer Pain Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Cancer Pain Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Cancer Pain Market Size and Forecast (2019-2030)
    • 8.3.5 India Cancer Pain Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Cancer Pain Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Cancer Pain Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Cancer Pain Consumption Value by Type (2019-2030)
  • 9.2 South America Cancer Pain Consumption Value by Application (2019-2030)
  • 9.3 South America Cancer Pain Market Size by Country
    • 9.3.1 South America Cancer Pain Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Cancer Pain Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Cancer Pain Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cancer Pain Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Cancer Pain Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Cancer Pain Market Size by Country
    • 10.3.1 Middle East & Africa Cancer Pain Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Cancer Pain Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Cancer Pain Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Cancer Pain Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Cancer Pain Market Drivers
  • 11.2 Cancer Pain Market Restraints
  • 11.3 Cancer Pain Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Cancer Pain Industry Chain
  • 12.2 Cancer Pain Upstream Analysis
  • 12.3 Cancer Pain Midstream Analysis
  • 12.4 Cancer Pain Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Cancer Pain. Industry analysis & Market Report on Cancer Pain is a syndicated market report, published as Global Cancer Pain Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Cancer Pain market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo